These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 8774129)
1. Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas. Bohle RM; Brettreich S; Repp R; Borkhardt A; Kosmehl H; Altmannsberger HM Am J Pathol; 1996 Mar; 148(3):731-8. PubMed ID: 8774129 [TBL] [Abstract][Full Text] [Related]
2. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis. Sakamoto A; Oda Y; Adachi T; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612 [TBL] [Abstract][Full Text] [Related]
3. H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma. Sakamoto A; Oda Y; Itakura E; Oshiro Y; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M Hum Pathol; 2001 Nov; 32(11):1225-31. PubMed ID: 11727262 [TBL] [Abstract][Full Text] [Related]
4. H-ras-1 point mutations in soft tissue sarcomas. Wilke W; Maillet M; Robinson R Mod Pathol; 1993 Mar; 6(2):129-32. PubMed ID: 8483882 [TBL] [Abstract][Full Text] [Related]
5. H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients. Yoo J; Robinson RA Cancer; 1999 Jul; 86(1):58-63. PubMed ID: 10391564 [TBL] [Abstract][Full Text] [Related]
6. H-ras and K-ras gene mutations in primary human soft tissue sarcoma: concomitant mutations of the ras genes. Yoo J; Robinson RA; Lee JY Mod Pathol; 1999 Aug; 12(8):775-80. PubMed ID: 10463479 [TBL] [Abstract][Full Text] [Related]
7. K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654 [TBL] [Abstract][Full Text] [Related]
8. Malignant fibrous histiocytomas and H-ras-1 oncogene point mutations. Rieske P; Bartkowiak J; Szadowska A; Debiec-Rychter M Mol Pathol; 1999 Apr; 52(2):64-7. PubMed ID: 10474683 [TBL] [Abstract][Full Text] [Related]
9. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Tada M; Omata M; Ohto M Cancer Res; 1990 Feb; 50(4):1121-4. PubMed ID: 2153451 [TBL] [Abstract][Full Text] [Related]
10. p53 gene mutations and p53 protein expression in human soft tissue sarcomas. Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310 [TBL] [Abstract][Full Text] [Related]
11. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2. Przygodzki RM; Finkelstein SD; Keohavong P; Zhu D; Bakker A; Swalsky PA; Soini Y; Ishak KG; Bennett WP Lab Invest; 1997 Jan; 76(1):153-9. PubMed ID: 9010458 [TBL] [Abstract][Full Text] [Related]
12. [Detection of point mutation of p53 gene by silver staining PCR-SSCP in paraffin-embedded malignant fibrous histiocytoma]. Li J; Yang G; Li G Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):13-5. PubMed ID: 8732103 [TBL] [Abstract][Full Text] [Related]
13. The rise and fall of malignant fibrous histiocytoma. Erlandson RA; Antonescu CR Ultrastruct Pathol; 2004; 28(5-6):283-9. PubMed ID: 15764577 [TBL] [Abstract][Full Text] [Related]
14. Beta-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma. Sakamoto A; Oda Y; Adachi T; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M Arch Pathol Lab Med; 2002 Sep; 126(9):1071-8. PubMed ID: 12204056 [TBL] [Abstract][Full Text] [Related]
15. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing. Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449 [TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Larramendy ML; Tarkkanen M; Blomqvist C; Virolainen M; Wiklund T; Asko-Seljavaara S; Elomaa I; Knuutila S Am J Pathol; 1997 Oct; 151(4):1153-61. PubMed ID: 9327749 [TBL] [Abstract][Full Text] [Related]
17. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis. Sakamoto A; Oda Y; Adachi T; Oshiro Y; Tamiya S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351 [TBL] [Abstract][Full Text] [Related]
18. High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas. Ohashi K; Tsutsumi M; Nakajima Y; Noguchi O; Okita S; Kitada H; Tsujiuchi T; Kobayashi E; Nakano H; Konishi Y Jpn J Clin Oncol; 1994 Dec; 24(6):305-10. PubMed ID: 7830335 [TBL] [Abstract][Full Text] [Related]
19. Activation of RAS family genes in urothelial carcinoma. Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097 [TBL] [Abstract][Full Text] [Related]
20. SAS amplification in soft tissue sarcomas. Smith SH; Weiss SW; Jankowski SA; Coccia MA; Meltzer PS Cancer Res; 1992 Jul; 52(13):3746-9. PubMed ID: 1319830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]